Page 158 - 2024 Taiwan Health and Welfare Report
P. 158

2024 Taiwan Health and Welfare Report




               development, clinical trials, consultation and training.   connection software updates. In addition, access
               Since 2019, the two transferred manufacturers   policy management equipment setup and remote
               were assisted in conducting Phase III clinical trials in   connection software update have been completed.
               Vietnam. The manufacturers successively obtained   2. Service Content and Service Quantity
               formal drug permit licenses from Taiwan Food and   In 2023, the number of database opened for
               Drug Administration in January and April of 2023.   application was adjusted to 112 and the HWDC
               The vaccine became available for public vaccination   including the headquarters and 10 research sub-
               starting in July, marking Taiwan's first vaccine   centers provided 125 computers for services.
               developed entirely domestically from strain selection,   Due to the relocation of partial operating sites and
               R&D, technology transfer to market launch.      hardware replacement, the operating days in 2023
            4. NHRI Bioproduction Plant II and National Infectious   was fewer than in 2022, as well as conclusion of
               Diseases Bank                                   some large-scale research used in research sub-

               In response to the COVID-19 pandemic to safeguard   centers, person-days of service, annual case-times
               public health and safety with government and private   of actual usage and case-times of reviewed statistic
               sector support, NHRI planned the Bioproduction   result carried out (Table 12-1) decreased by an
               Plant II and National Infectious Diseases Bank (NIDB)   average of one-tenth compared to 2022.
               facilities. Groundbreaking was held on October 12,   3. Promoting Database Leading to R&D of Biomedicine
               2023 at the NHRI Zhunan campus.
                                                               (1)  The inter-agency "Sustainable Platform for
            Section 3  Application Service of Health             Big Data in Health" project was successively
                                                                 completed the lung cancer and breast cancer
                        and Welfare Data
                                                                 thematic databases in 2023 and opened for
            1. Management of Applications Service Platform       application, while the cardiovascular disease
               The Health and Welfare Data Science Center        thematic database will go soon be available online
               (HWDC) has continued to collaborate with the      at the Ministry's Statistics Center and National
               "Health Big Data Sustainable Platform" project in   Health Insurance Administration respectively.
               2023 by opening the lung cancer and breast cancer   (2)  The "Cancer Precision Medicine and Biobank
               topic databases cooperatively established with NHRI   Consortium Collaboration Pilot Project" marked the
               for external application use. The high-density storage   first large-scale international collaboration project
               of the "Health Big Data Zone" has been expanded   between the public and private (industry) sectors
               from 900TB to 1,500TB, with completion of access   under the MOHW. This project involves 12 hospitals
               policy management equipment setup and remote      and 4 international pharmaceutical companies and





























                    Groundbreaking Ceremony for Bioproduction Plant and National Infectious Diseases
                    Bank Platform
     156
   153   154   155   156   157   158   159   160   161   162   163